Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 4/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26397632 | 0.95 | MAPT (0.90) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL11710601 | 0.85 | MEN1 (0.74) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL11710607 | 0.85 | MAPT (0.74) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL29286771 | 0.84 | MAPT (0.72) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL29728198 | 0.84 | MAPT (0.72) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL1285643 | 0.84 | ALDH1A1 (0.73) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL5398875 | 0.84 | CYP1A2 (0.76) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL29205280 | 0.84 | CYP1A2 (0.76) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL31152634 | 0.84 | ALDH1A1 (0.73) | MAPTMEN1KMT2AL3MBTL1POLB | |
| SCHEMBL1913977 | 0.84 | ALDH1A1 (0.73) | MAPTMEN1KMT2AL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12207486-B2 | Light-emitting element for restraining degradation of electrical and optical properties | SHARP KABUSHIKI KAISHA (JP) | 2025-01-21 | — | — | US | claimed |
| US-20240090251-A1 | LIGHT-EMITTING ELEMENT | SHARP KABUSHIKI KAISHA (JP) | 2024-03-14 | — | — | US | claimed |
| CN-107402206-B | Mercury ion colorimetric sensor and preparation method and application thereof | 闽南师范大学 | 2020-04-07 | — | — | CN | claimed |
| CN-107402206-A | A kind of mercury ion colorimetric sensing device and its preparation method and application | 闽南师范大学 | 2017-11-28 | — | — | CN | claimed |
| US-8975283-B2 | Pharmacologically active compounds containing sulfur | JON PTY LIMITED (AU) | 2015-03-10 | — | — | US | claimed |
| EP-2724156-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE | The Jackson Laboratory (US) | 2014-04-30 | — | — | EP | claimed |
| CN-103765212-A | Methods and compositions for treating cancer and autoimmune diseases | JACKSON LAB | 2014-04-30 | — | — | CN | claimed |
| US-20130123504-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING SULFUR | JON PTY LIMITED (AU) | 2013-05-16 | — | — | US | claimed |
| US-8362041-B2 | Pharmacologically active compounds containing sulfur | JON PTY LIMITED (AU) | 2013-01-29 | — | — | US | claimed |
| WO-2013003112-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND AUTOIMMUNE DISEASE | THE JACKSON LABORATORY (US) | 2013-01-03 | — | — | WO | claimed |
| US-6495247-B1 | A COORDINATE BOND BEING A MULTIDENTATE BOND WHERE A MOLECULE BONDS WITH METALLIC ATOM ON SURFACE AND THE METALLIC ATOM IS BETWEEN THE LIGAND ATOMS | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-12-17 | — | — | US | claimed |
| US-20020169309-A1 | Mutation detection method | GJERDE DOUGLAS T (US) | 2002-11-14 | — | — | US | claimed |
| US-20020164589-A1 | Detection of nucleic acid heteroduplex molecules by anion-exchange chromatography | ADS BIOTEC INC. | 2002-11-07 | — | — | US | claimed |
| EP-1226275-A2 | DETECTION OF NUCLEIC ACID HETERODUPLEX MOLECULES BY ANION-EXCHANGE CHROMATOGRAPHY | TRANSGENOMIC, Inc. (US) | 2002-07-31 | — | — | EP | claimed |
| WO-2001027331-A2 | DETECTION OF NUCLEIC ACID HETERODUPLEX MOLECULES BY ANION-EXCHANGE CHROMATOGRAPHY | TRANSGENOMIC, INC. (US) | 2001-04-19 | — | — | WO | claimed |
| EP-1002137-A1 | DENATURING MULTI ION POLYNUCLEOTIDE CHROMATOGRAPHY FOR DETECTING MUTATIONS | TRANSGENOMIC, Inc. (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999007899-A1 | DENATURING MULTI ION POLYNUCLEOTIDE CHROMATOGRAPHY FOR DETECTING MUTATIONS | TRANSGENOMIC, INC. (US) | 1999-02-18 | — | — | WO | claimed |
| US-5824630-A | DETERGENCY BUILDER, INORGAIC PEROXYHYDRATE BLEACHING AGENT, PARAFFIN OIL, NITROGEN CONTAINING CORROSION INHIBIOR COMPOUND, MERCAPTAN CORROSION INHIBITOR | THE PROCTER & GAMBLE COMPANY | 1998-10-20 | — | — | US | claimed |
| US-5747438-A | STORAGE STABILITY | THE PROCTER & GAMBLE COMPANY (US) | 1998-05-05 | — | — | US | claimed |
| US-4320209-A | Amide nucleating agents for butene-1 polymer compositions | SHELL OIL COMPANY (US) | 1982-03-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123504-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING SULFUR | SCLY, STS, SQOR | MAPT 4757/4885MEN1 4257/4885KMT2A 3893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.